Prevalencia de linfoma de Hodgkin en pacientes que ingresan al área de hematología del Hospital de SOLCA en Guayaquil.

Abstract

Hodgkin lymphoma (HL) is a B-cell lymphoma characterized by the presence of a few malignant cells and numerous immune effector cells in the tumor microenvironment. Its incidence is higher in adolescents and young adults, although it can affect older individuals. Objective: To determine the prevalence of Hodgkin lymphoma in patients admitted to the Hematology Department of SOLCA Hospital in Guayaquil. Methodology: The study was descriptive, quantitative, with a retrospective, cross-sectional design. Population: 214 patients diagnosed with Hodgkin lymphoma. Technique: Indirect observation. Instrument: Observation form. Results: Demographic characteristics showed that they were 54% male and 46% female, aged 15 to 29 years 35% and 30 to 44 years 19% of mestizo ethnicity 62%, montubio 15% and Afro-Ecuadorian 13% coming from the Costa region 69% and Sierra 27%. Clinical manifestations showed symptoms b (fever, weight loss, sweating) 67%, bulky mass 10%, abdominal pain 7% and fatigue 6%. Previous comorbidities show that they have no clinical history 77%. In stages according to the Ann Arbor system, II 46%, III 26%, I 16% and IV 12%. With chemotherapy treatment (ABVD regimen) 67%, palliative and supportive care 12%, radiotherapy 11% and rescue therapies (such as ESHAP, ICE, DHAP) 10%. Conclusion: The prevalence of Hodgkin lymphoma during the period 2023 to 2024 was 4.99%.